A 52-year-old man with a 10-year history of hypertension presents to the emergency department with acute dyspnea and orthopnea. On examination, blood pressure is 165/105 mmHg, heart rate 110 bpm, and JVP is elevated at 8 cm H₂O. Chest X-ray shows pulmonary edema. Echocardiography reveals a dilated left ventricle with ejection fraction of 35%. Which of the following mechanisms BEST explains the reduced cardiac output in this patient despite increased sympathetic activation?

Explanation

## Pathophysiology of Reduced Cardiac Output in Chronic Hypertension **Key Point:** In chronic hypertension with left ventricular dysfunction, the primary mechanism limiting cardiac output is impaired contractility from myocardial remodeling, not simply increased afterload. ### Mechanism of LV Dysfunction in Chronic Hypertension Chronic pressure overload triggers a sequence of adaptive and maladaptive changes: 1. **Initial phase (compensation):** Concentric hypertrophy maintains wall stress and ejection fraction 2. **Decompensation phase:** Progressive fibrosis, myocyte loss, and chamber dilation → reduced contractility 3. **End-stage:** Dilated cardiomyopathy with systolic dysfunction (EF 35% in this case) ### Why Contractility, Not Afterload Alone, Is the Problem | Factor | Role in This Patient | |--------|----------------------| | **Afterload** | Elevated (BP 165/105), but compensatory mechanisms partially offset this via sympathetic activation and increased contractility | | **Contractility** | Severely impaired (EF 35%) due to chronic myocardial remodeling, fibrosis, and apoptosis | | **Preload** | Elevated (JVP 8 cm, orthopnea, pulmonary edema) — the ventricle is operating on the flat part of the Frank-Starling curve | **Clinical Pearl:** The dilated ventricle with low EF indicates that the problem is intrinsic myocardial dysfunction, not just hemodynamic loading. Sympathetic activation (HR 110) is maximal but cannot overcome the loss of contractile force. **High-Yield:** In systolic heart failure (EF <40%), the limiting factor for CO is contractility. Afterload reduction (vasodilators, ACE inhibitors) improves CO by reducing the impedance to ejection, but the fundamental defect is myocardial weakness from remodeling. ### Cardiac Output Regulation Formula $$CO = HR \times SV$$ $$SV = (EDV - ESV) \times \text{Ejection Fraction}$$ In this patient: - HR is elevated (compensatory) ✓ - EF is severely reduced (35% vs. normal 60%) ✗ - Result: CO remains low despite tachycardia [cite:Harrison 21e Ch 297]